Skip to main content
    M

    Microbot Medical Inc (MBOT)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $0.64
    -0.33 (-34.16%)

    Market Cap: $65.73M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Microbot Medical Inc (MBOT) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Microbot Medical (MBOT) trades at 125.1x sales and 0.6x book value. Its P/B of 0.6x is below its 5-year median of 2.7x. Its forward P/E is 31.8x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E31.8x
    Price to sales125.1x
    Price to book0.6x
    PEGN/A
    FCF yield-41.4%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/B is 78.6% below 2.8x.

    MultipleCurrent5-year median10-year median
    P/B0.6x2.7x2.8x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 116 months (10-year).

    Valuation History

    Over the 9 of the 10 year ends shown that have a P/B, its P/B ranged from 1.7x in 2025 to 5.4x in 2024. 2025 was the lowest of those years.

    Year endPriceP/SP/B
    2025$2.00N/A1.7x
    2024$1.12226.9x5.4x
    2023$1.64140.1x4.4x
    2022$3.01N/A3.2x
    2021$7.50N/A3.7x
    2020$6.89N/A2.0x
    2019$10.17N/A2.3x
    2018$1.72N/A5.3x
    2017$15.29N/A4.2x
    2016$91.45N/AN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    Frequently Asked Questions About MBOT

    What is MBOT's forward P/E ratio?

    Microbot Medical has a forward P/E ratio of 31.8x.

    What is MBOT's price to sales ratio?

    Microbot Medical has a price to sales ratio of 125.1x.